{
    "table_id": "finqa_9f32b4b22e",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "ABMD/2012/page_75.pdf-1",
        "pre_text_caption_evidence": [
            "abiomed , inc .",
            "and subsidiaries notes to consolidated financial statements 2014 ( continued ) note 8 .",
            "stock award plans and stock-based compensation ( continued ) restricted stock and restricted stock units the following table summarizes restricted stock and restricted stock unit activity for the fiscal year ended march 31 , 2012 : number of shares ( in thousands ) weighted average grant date fair value ( per share ) ."
        ],
        "question": "during the 2012 year , did the equity awards in which the prescribed performance milestones were achieved exceed the equity award compensation expense for equity granted during the year?"
    },
    "dimensions": {
        "rows": 5,
        "columns": 3
    },
    "schema": {
        "columns": [
            "",
            "number of shares ( in thousands )",
            "weighted average grant date fair value ( per share )"
        ],
        "dtypes": {
            "": "object",
            "number of shares ( in thousands )": "object",
            "weighted average grant date fair value ( per share )": "object"
        }
    }
}